Medical Digest & Congress Report
Episodes
What clinicians must know about diabetic dyslipidemia - report from WCCL 2025
07 Jul 2025
Contributed by Lukas
Professor Martin Clodi shares his insights what clinicians must know about diabetic dyslipidemia at the 4th World Congress of Lipidology in Vienna, Au...
How to implement LDL guidelines? - report from WCCL 2025
04 Jul 2025
Contributed by Lukas
Professor Gerald Watts shares his insights how to implement LDL guidelines at the 4th World Congress of Lipidology in Vienna, Austria.Video: https://m...
Newborn Screening for Atherosclerosis Risk? - report from WCCL 2025
04 Jul 2025
Contributed by Lukas
Professor Caroline Bachmeier shares her insights on the rationale of small children and newborn screening for atherosclerosis at the 4th World Congres...
What will change in the lipid lowering landscape in the next 5 years? - report from WCCL 2025
04 Jul 2025
Contributed by Lukas
Professor Maciej Banach shares his insights what will change in the lipid lowering landscape in the next 5 years at the 4th World Congress of Lipidolo...
Diabetic Dyslipidemia: Beyond LDL – Atherogenic Lipoproteins in Focus - report from WCCL 2025
03 Jul 2025
Contributed by Lukas
Professor Gersina Rega Kaun shares her insights on lipid lowering in diabetics at the 4th World Congress of Lipidology in Vienna, Austria.Video: https...
LDL lowering in 2025: Optimal approach - report from WCCL 2025
03 Jul 2025
Contributed by Lukas
Professor Dereck Connolly shares his insights on LDL lowering in 2025 at the 4th World Congress of Lipidology in Vienna, Austria.Video: https://medica...
POLARGO Trial Shows OS Benefit with Pola-R-GemOx in Transplant-Ineligible R/R DLBCL - report from EHA2025
27 Jun 2025
Contributed by Lukas
Professor Matthew Matasar explains the highly anticipated results of the Phase III POLARGO trial after the 2025 EHA Annual Meeting.Video: https://medi...
Asciminib in the treatment of CML - report from EHA2025
27 Jun 2025
Contributed by Lukas
Professor Dennis Kim shares his insights on the asciminib in the treatment of chronic myeloid leukemia after the 2025 EHA Annual Meeting.Video: https:...
AML Highlights from EHA 2025
27 Jun 2025
Contributed by Lukas
Professor Petya Apostolova shares her insights on the Acute Myeloid Leukemia highlights from the 2025 EHA Annual Meeting.Video: https://medicaldigest....
Advances in Post-Covalent Bruton`s Tyrosine Kinase Inhibitor Therapy for Relapsed/Refractory Chronic Lymphocytic Leukemia - report from EHA2025
27 Jun 2025
Contributed by Lukas
Professor Matthew Davids shares his insights on the advances in post-covalent Bruton`s tyrosine kinase inhibitor therapy for relapsed/refractory chron...
Frontline Therapy of B-cell Acute Lymphoblastic Leukemia: Harnessing Innovative Approaches to Improve Outcomes - report from EHA2025
27 Jun 2025
Contributed by Lukas
Professor Martin Schrappe shares his insights on the frontline therapy of B-cell acute lymphoblastic leukemia at the 2025 EHA Annual Meeting.Video: ht...
Diffuse large B cell lymphoma: Bispecifics in focus - report from EHA2025
26 Jun 2025
Contributed by Lukas
Professor Martin Hutchings shares his insights on the role of bispecifics int the treatment of diffuse large B cell lymphoma at the 2025 EHA Annual Me...
How to educate haematologists to better identify Gaucher disease? - report from EHA2025
26 Jun 2025
Contributed by Lukas
Professor Sam Salek discusses how to educate haematologists to better identify Gaucher disease at the 2025 EHA Annual Meeting.Video: https://medicaldi...
Management of Multiple Myeloma at EHA 2025
26 Jun 2025
Contributed by Lukas
Professor Evangelos Terpos shares his insights on the management of Multiple Myeloma at the 2025 EHA Annual Meeting.Video: https://medicaldigest.org/s...
Highlights of Diffuse Large B-Cell Lymphoma at EHA 2025
26 Jun 2025
Contributed by Lukas
Professor Thomas Oellerich shares his insights on the highlights of Diffuse Large B-Cell Lymphoma at the 2025 EHA Annual Meeting.Video: https://medica...
Emerging Insights in the Secondary Acute Myeloid Leukemia in 2025 - report from EHA2025
26 Jun 2025
Contributed by Lukas
Professor Agnieszka Wierzbowska shares her thoughts on emerging insights in the secondary acute myeloid leukemia at the 2025 EHA Annual Meeting.Video:...
Combination Therapy For The Treatment Of Hypertension - report from ESH2025
26 Jun 2025
Contributed by Lukas
Professor Paul K. Whelton shares his insights on combination therapy for the treatment of hypertension after the 34th European Meeting on Hypertension...
The Role of CAR T-cell Therapy in Multiple Myeloma - report from EHA2025
25 Jun 2025
Contributed by Lukas
Professor Doris Hansen shares her insights on the role of CAR T-cell therapy in Multiple Myeloma at the 2025 EHA Annual Meeting.Video: https://medical...
Multiple Myeloma update at EHA 2025
25 Jun 2025
Contributed by Lukas
Professor Andrzej Jakubowiak shares his insights on multiple myeloma updates at the 2025 EHA Annual Meeting.Video: https://medicaldigest.org/scientifi...
Shaping the Treatment Landscape in Myelodysplastic Syndromes and Acute Myeloid Leukemia - report from EHA2025
25 Jun 2025
Contributed by Lukas
Professor Gail Roboz shares her insights on the treatment landscape in myelodysplastic syndromes and acute myeloid leukemia at the 2025 EHA Annual Mee...
New therapeutic options and translational insights in ALL - report from EHA2025
25 Jun 2025
Contributed by Lukas
Professor Cristina Papayannidis shares her insights on the new therapeutic options in acute lymphocytic leukemia at the 2025 EHA Annual Meeting.Video:...
Exploring the Landscape for FLT3-mutated Relapsed/Refractory Acute Myeloid Leukaemia - report from EHA2025
25 Jun 2025
Contributed by Lukas
Professor Adolfo de la Fuente Burguera shares his insights on the landscape for FLT3-mutated relapsed/refractory acute myeloid leukaemia at the 2025 E...
How to Improve the Awareness in Gaucher Disease? - report from EHA2025
25 Jun 2025
Contributed by Lukas
Professor Pilar Giraldo shares her insights on how to improve the awareness in Gaucher disease at the 2025 EHA Annual Meeting.Video: https://medicaldi...
Mapping the Evolving Chronic Lymphocytic Leukemia Treatment Landscape for the Optimal Patient Journey and Experience - report from EHA2025
25 Jun 2025
Contributed by Lukas
Professor Dima El-Sharkawi shares her insights on the evolving chronic lymphocytic leukemia treatment landscape for the optimal patient journey and ex...
Optimising the Management of FLT3mut+ R/R AML - report from EHA2025
25 Jun 2025
Contributed by Lukas
Professor Mark Levis shares his insights on optimising the management of FLT3mut+ R/R AML at the 2025 EHA Annual Meeting.Video: https://medicaldigest....
ALL Highlights from EHA 2025
23 Jun 2025
Contributed by Lukas
Professor Sebastian Giebel shares his insights on the Acute Lymphoblastic Leukemia highlights from the 2025 EHA Annual Meeting.Video: https://medicald...
First-Steps With Time-Limited BTKi-B–cell lymphoma 2 Inhibitor Options in Treatment Naïve CLL - report from EHA2025
23 Jun 2025
Contributed by Lukas
Professor Lydia Scarfò shares her insights on BTKi-B–cell lymphoma 2 inhibitor options in treatment naïve CLL at the 2025 EHA Annual Meeting.Video...
Improving Patient Outcome in Secondary Acute Myeloid Leukemia in 2025 - report from EHA2025
23 Jun 2025
Contributed by Lukas
Professor Livio Pagano discusses improving patient outcome in secondary acute myeloid leukemia at the 2025 EHA Annual Meeting.Video: https://medicaldi...
The Second Coming of Finite Therapy in Chronic Lymphocytic Leukemia - report from EHA2025
23 Jun 2025
Contributed by Lukas
Professor Nicole Lamanna shares her insights on second-generation BTKi combinations at the 2025 EHA Annual Meeting.Video: https://medicaldigest.org/sc...
The Unprecedented Progress on the Treatment of Relapsed and Refractory Multiple Myeloma in 2025 - report from EHA2025
23 Jun 2025
Contributed by Lukas
Professor Enrique M. Ocio discusses progress on the treatment of relapsed and refractory multiple myeloma at the 2025 EHA Annual Meeting.Video: https:...
Honorary President's take on the highlights of ESH 2025 meeting - report from ESH2025
17 Jun 2025
Contributed by Lukas
Professor Giuseppe Mancia shares his insights on the most inportant highlights of ESH 2025 meeting. Video: https://medicaldigest.org/scientific-conten...
Build a strong therapeutic alliance with your patient: with a little help from your friends - report from ESH2025
17 Jun 2025
Contributed by Lukas
Professor Michel Burnier participated in a session of the 34th European Meeting on Hypertension and Cardiovascular protection in Milan, Italy which ad...
Let’s target success for every patient: Achieving blood pressure control in high-risk patients - report from ESH2025
17 Jun 2025
Contributed by Lukas
Professor George S. Stergiou co-chaired a session at the 34th European Meeting on Hypertension and Cardiovascular protection in Milan, Italy focused o...
Patients and doctors’ partnership: Should we change the paradigm to improve blood pressure control? - report from ESH2025
17 Jun 2025
Contributed by Lukas
Professor Rosa de Pinho co-chaired a session at the 34th European Meeting on Hypertension and Cardiovascular protection in Milan, Italy focused on fac...
Cracking the code of resistant hypertension: From challenges to solutions - report from ESH2025
17 Jun 2025
Contributed by Lukas
Professor Stefano Taddei shares his insights on resistant hypertension, that has been thoroughly discussed at many sessions of the 34th European Meeti...
Combining vaccines is the future of vaccination - report from WVCDC 2025
07 May 2025
Contributed by Lukas
Mark Jit shares his insights on the combination vaccines on the future of vaccination at the World Vaccine Congress Washington 2025.Video: https://med...
Addressing the burden of long Covid: reaching a global consensus - report from WVCDC 2025
07 May 2025
Contributed by Lukas
Miranda Baxa shares her insights on the burden of long Covid at the World Vaccine Congress Washington 2025.Important documents:The future of covid Add...
Benefits and challenges of combining vaccines - report from WVCDC 2025
07 May 2025
Contributed by Lukas
Bill Hausdorff shares his insights on the benefits and challenges of combining vaccines at the World Vaccine Congress Washington 2025.Video: https://m...
Which vaccination programs with pandemic potential have worked and what else can be done to repurpose COVID facilities and incorporate novel platforms? - report from WVCDC 2025
07 May 2025
Contributed by Lukas
Rajinder Suri shares his insights on which vaccination programs with pandemic potential have worked and what else can be done to repurpose COVID facil...
Clinical Updates for a novel preventative breast cancer vaccine - report from WVCDC 2025
07 May 2025
Contributed by Lukas
Olivera Finn shares her insights on clinical updates for a novel preventative breast cancer vaccine at the World Vaccine Congress Washington 2025.Vide...
Cell-Based Therapeutic Vaccination as Adjuvant Therapy for MGMT Unmethylated Glioblastoma - report from WVCDC 2025
07 May 2025
Contributed by Lukas
William Decker shares his insights on cell-based therapeutic vaccination as adjuvant therapy for MGMT unmethylated glioblastoma at the World Vaccine C...
Intranasal Universal Influenza Vaccine: Promising Data on Blocking Virus Transmission - report from WVCDC 2025
07 May 2025
Contributed by Lukas
Amy Aspelund shares her insights on intranasal universal influenza vaccines at the World Vaccine Congress Washington 2025.Video: https://medicaldigest...
Highlights of ACC.25
09 Apr 2025
Contributed by Lukas
Hadley Wilson, ACC Immediate Past President shares his insights on the key announcements and findings at the American College of Cardiology’s Annual...
Chronic Coronary Disease Management in 2025: What's New in the Guidelines? - report from ACC.25
09 Apr 2025
Contributed by Lukas
Benjamin H. Freed co-chaired an interesting session on Chronic Coronary Disease Management in 2025 at the American College of Cardiology’s Annual Sc...
Arrhythmia Management: Updates From Recent Practice Guidance Documents - report from ACC.25
09 Apr 2025
Contributed by Lukas
John K. Triedman shares his insights on the joint symposium of the Heart Rhythm Society and the American College of Cardiology, that will highlight re...
Chief Medical Officer's take on ACC.25
09 Apr 2025
Contributed by Lukas
Richard Kovacs shares his insights on key announcements and findings at the American College of Cardiology’s Annual Scientific Session.Video: https:...
Why lipoprotein(a) matters for clinical decisions and patient risk? - report from ACC.25
09 Apr 2025
Contributed by Lukas
Martha Gulati shares her insights on lipoprotein(a) and atherosclerotic cardiovascular disease at the American College of Cardiology’s Annual Scient...
Discussion on Optimizing Hypertension Management: We Need New Treatment and Interventions - report from ACC.25
08 Apr 2025
Contributed by Lukas
Paul K. Whelton shares his insights on optimizing hypertension management at the American College of Cardiology’s Annual Scientific Session.Video: h...
Lifetime Benefit by Control of Modifiable Risk Factors - report from ACC.25
08 Apr 2025
Contributed by Lukas
Christina Magnussen on individual-level data collected across 126 worldwide cohorts show controlling modifiable cardiovascular risk factors can potent...
Dapagliflozin Reduced LVMI in Patients with CKD : DECODE-CKD - report from ACC.25
08 Apr 2025
Contributed by Lukas
Tor Biering-Sørensen presented the analysis of the primary and secondary endpoint results of the DECODE-CKD at the American College of Cardiology’s...
Nurse-led behavior changes after heart attack cut subsequent event risk by 30% - report from ACC.25
08 Apr 2025
Contributed by Lukas
Giulia Magnani explains a nurse-coordinated intensive intervention program emphasizing lifestyle and behavioral changes after ACS was associated with ...
Lorundrostat shows continued promise against uncontrolled hypertension - report from ACC.25
08 Apr 2025
Contributed by Lukas
Luke Laffin on the phase 2b Advance-HTN study of lorundrostat, whose results were reported in a late-breaking clinical trials presentation at the Amer...
Shifting the Paradigm: Lipoprotein(a) in Cardiovascular Disease - report from ACC.25
08 Apr 2025
Contributed by Lukas
Alan Brown shares his insights on lipoprotein(a) and atherosclerotic cardiovascular disease at the American College of Cardiology’s Annual Scientifi...
ALIGN-AR reports positive outcomes with dedicated TAVI device for aortic regurgitation - report from ACC.25
08 Apr 2025
Contributed by Lukas
Raj Makkar explains data from 500 patients treated for aortic regurgitation with the Trilogy transcatheter aortic valve implantation system, point tow...
From Evidence Generation to Implementation: Tackling Unmet Need in ASCVD - report from ACC.25
08 Apr 2025
Contributed by Lukas
Ankeet S. Bhatt shares his insights how real-world evidence and implementation science can improve ASCVD care at the American College of Cardiology’...
Stepping into the future of care for patients with peripheral artery disease with the 2024 guidelines - report from ACC.25
04 Apr 2025
Contributed by Lukas
Heather L. Gornik shares her insights on future of care for patients with peripheral artery disease with the 2024 guidelines'. Video: https://medi...
Intravenous iron offers some benefits for some patients with heart failure - report from ACC.25
04 Apr 2025
Contributed by Lukas
Stefan D. Anker explains among iron-deficient patients with heart failure with reduced ejection fraction, receiving intravenous iron supplementation w...
Semaglutide improves walk distance for PAD patients with diabetes - report from ACC.25
04 Apr 2025
Contributed by Lukas
Marc P. Bonaca explains semaglutide significantly improved maximal walking distance in people with symptomatic peripheral arterial disease and type 2 ...
TAVR comparable to open heart surgery after 5 years in low-risk patients - report from ACC.25
04 Apr 2025
Contributed by Lukas
Michael J. Reardon explains the new five-year data suggest transcatheter aortic valve replacement with a supra-annular, self-expanding valve is a safe...
Oral semaglutide reduces cardiovascular events by 14% at four years - report from ACC.25
04 Apr 2025
Contributed by Lukas
Darren K. McGuire explains people taking an oral formulation of semaglutide were 14% less likely than those taking a placebo to experience cardiovascu...
Research shows clopidogrel as better long-term therapy than aspirin after PCI - report from ACC.25
04 Apr 2025
Contributed by Lukas
Joo-Yong Hahn shares his insights on the research presented at the American College of Cardiology's Annual Scientific Session. People at high risk...
Low-dose apixiban comparable to full dose for preventing VTE recurrence in patients with cancer - report from ACC.25
04 Apr 2025
Contributed by Lukas
Isabelle Mahé shares her insights API-CAT trial were presented at the American College of Cardiology’s Annual Scientific Session.Video: https://med...
WARRIOR study: Intensive medical therapy does not help or harm women with chest pain - report from ACC.25
04 Apr 2025
Contributed by Lukas
Eileen M. Handberg, PhD, ARNP, FACC and C. Noel Bairey Merz, MD, FACC, FAHA shares their insights on the WARRIOR study, presented at the American Coll...
Redefining Risk of Recurrence: Latest advances with CDK4/6 inhibitors in HR+/HER2− early breast cancer
21 Mar 2025
Contributed by Lukas
Michael Gnant have been the Co-Chair of the highly successful, annual St Gallen Breast Cancer Conference in Vienna, and chaired a session about the la...
Why there is no such thing as a psychiatric diagnosis?
18 Mar 2025
Contributed by Lukas
Sami Timimi indicated in his presentation at the RCPsych in Scotland Winter Conference that formal psychiatric diagnostic systems should be abolished....
Comparative efficacy and acceptability of pharmacological, psychological, and neurostimulatory interventions for ADHD in adults: a systematic review and component network meta-analysis
12 Mar 2025
Contributed by Lukas
Edoardo Ostinelli, Senior Researcher & Deputy Lead of Oxford Precision Psychiatry Lab at the Department of Psychiatry, University of Oxford, UK. H...
Social cognition in autism and ADHD
11 Mar 2025
Contributed by Lukas
Sven Bölte, professor of child and adolescent psychiatric science at Karolinska Institute, Stockholm, Sweden, renowned expert of neurodevelopmental d...
Addressing Comorbid Bipolar Disorder and ADHD
21 Feb 2025
Contributed by Lukas
Mark Jankelow, MSN, PMHNP-BC summarizes his presentation at Real Psychiatry 2025 on bipolar disorder and ADHD and shares his 20 years of experience wi...
Management of Multiple Myeloma at ASH 2024
24 Jan 2025
Contributed by Lukas
Professor Paul G. Richardson summarizes the most important highlights in the field of Multiple Myeloma treatment after the 2024 ASH Annual Meeting. Vi...
Highligths of SABCS 2024
08 Jan 2025
Contributed by Lukas
Kate Lathrop, MD discuss some of the high impact, clinically relevant, clinical trials that were presented at the San Antonio Breast Cancer Symposium ...
Early Breast Cancer Updates - report from SABCS2024
07 Jan 2025
Contributed by Lukas
Janice Tsang, MD discusses early breast cancer updates at San Antonio Breast Cancer Symposium 2024. Videó: https://medicaldigest.org/scientific-conte...
CLL Highlights from ASH 2024
07 Jan 2025
Contributed by Lukas
William G. Wierda, MD, PhD discusses current questions and state of the art treatement of chronic lymphocytic leukemia at the 2024 ASH Annual Meeting....
The Aymara Gene: A Tale of High Altitude and Human Evolution - report from ASH2024
22 Dec 2024
Contributed by Lukas
Josef T. Prchal, MD investigated the genetic basis underlying elevated hemoglobin in Andean natives, Aymara, by using granulocyte transcriptome data f...
State of the Art Treatment in Polycythemia Vera - report from ASH2024
22 Dec 2024
Contributed by Lukas
Aaron Gerds, MD, MS discusses the state of the art treatment in polycythemia vera at the 2024 ASH Annual Meeting. Video: https://medicaldigest.org/sc...
State of the Art Treatment in Myelofibrosis - report from ASH2024
22 Dec 2024
Contributed by Lukas
Aaron Gerds, MD, MS discusses the state of the art treatment in myelofibrosis at the 2024 ASH Annual Meeting. Video: https://medicaldigest.org/scienti...
Do GLP-1s Lower VTE Risk in People With Type 2 Diabetes? - report from ASH2024
22 Dec 2024
Contributed by Lukas
Cho Han Chiang, MD, MMSc presented an analysis at the 2024 ASH Annual Meeting, that shows GLP-1 receptor agonists led to a significant reduction in th...
24-hour Urine Testing does not Add Value to Multiple Myeloma Response Assessments - report from ASH2024
22 Dec 2024
Contributed by Lukas
Rahul Banerjee, MD, FACP comments on the role of 24-hour urine testing in assessing multiple myeloma treatment responses at the 2024 ASH Annual Meetin...
Bridging Gaps in Multiple Myeloma Care: A Community Oncologist's Guide to Navigating the Evolving Treatment Landscape - report from ASH2024
22 Dec 2024
Contributed by Lukas
Rahul Banerjee, MD, FACP discusses the state of the art treatment in Multiple Myeloma Care at the 2024 ASH Annual Meeting. Video: https://medicaldiges...
Crafting Custom Care in CLL: Guidance on Upfront and Sequential Treatment Decisions With Targeted and Immune-base Platforms - report from ASH2024
22 Dec 2024
Contributed by Lukas
Matthew S. Davids, MD, MMSc discusses the state of the art treatment in chronic lymphocytic leukemia at the 2024 ASH Annual Meeting. Video: https://me...
State of the Art Treatment in Adult ALL - report from ASH2024
22 Dec 2024
Contributed by Lukas
Anand A. Patel, MD discusses the state of the art treatment in adult acute lymphoblastic leukemia at the 2024 ASH Annual Meeting. Video: https://medi...
State of the Art Treatment in Lymphoma - report from ASH2024
22 Dec 2024
Contributed by Lukas
Catherine S. Diefenbach, MD discusses the state of the art treatment in lymphoma care at the 2024 ASH Annual Meeting. Video: https://medicaldigest.org...
Mastering the Art of Myelofibrosis Care: Expert Guidance, Clinical Experience, & Innovation for More Personalized Disease Control - report from ASH2024
22 Dec 2024
Contributed by Lukas
Prof. Francesco Passamonti discusses the state of the art treatment in myelofibrosis Care at the 2024 ASH Annual Meeting. Video: https://medicaldigest...
Addressing Current Questions and Controversies in the Management of Chronic Lymphocytic Leukemia - report from ASH2024
20 Dec 2024
Contributed by Lukas
Kerry A Rogers, MD discusses current questions and controversies in the management of chronic lymphocytic leukemia at the 2024 ASH Annual Meeting. Vid...
Addressing Current Questions and Controversies in the Management of Chronic Myeloid Leukemia - report from ASH2024
20 Dec 2024
Contributed by Lukas
Michael J. Mauro, MD discusses current questions and controversies in the management of chronic myeloid leukemia at the 2024 ASH Annual Meeting. Video...
State of the Art Treatment in Myelodysplastic Syndromes - report from ASH2024
20 Dec 2024
Contributed by Lukas
Mikkael A. Sekeres, MD, MS discusses the state of the art treatment in MDS at the 2024 ASH Annual Meeting. Video: https://medicaldigest.org/scientific...
Five-Year Analysis of the POLARIX Study - report from ASH2024
20 Dec 2024
Contributed by Lukas
Prof. Gilles Salles presented a 5-year analysis of the POLARIX study at the 2024 ASH Annual Meeting. Video: https://medicaldigest.org/scientific-conte...
Guiding Our Patient's Path: Managing First Relapse in Diffuse Large B-Cell Lymphoma Outside of CAR-Ts - report from ASH2024
20 Dec 2024
Contributed by Lukas
Prof. Gilles Salles discusses managing first relapse in diffuse large B-Cell lymphoma outside of CAR-Ts at the 2024 ASH Annual Meeting. Video: https:/...
Unraveling Data and Care Strategies for AL Amyloidosis - report from ASH2024
20 Dec 2024
Contributed by Lukas
Vaishali Sanchorawala, MD review the clinical challenges and intricacies of care associated with the management of light chain amyloidosis. Video: ht...
Bispecific Antibodies: A Playbook for Relapsed/Refractory Follicular Lymphoma - report from ASH2024
20 Dec 2024
Contributed by Lukas
Joshua Brody, MD discusses the advancing field of bispecific antibodies in third-line relapsed/refractory follicular lymphoma. Video: https://medicald...
Smoking Tied to Worsened Disease Progression in Myelodysplastic Syndromes - report from ASH2024
20 Dec 2024
Contributed by Lukas
Sangeetha Venugopal MD,MS discusses that smoking intensity and duration in patients with myelodysplastic syndromes were tied to distinct genetic mutat...
Addressing Current Questions and Controversies Regarding the Role of CAR T-Cell Therapy and Bispecific Antibodies in the Management of Lymphoma - report from ASH2024
20 Dec 2024
Contributed by Lukas
Martin Hutchings, MD, PhD discusses the role of CAR T-Cell therapy and bispecific antibodies in the management of lymphoma at the 2024 ASH Annual Meet...
Estrogen Receptor Mutations in HR+ Advanced Breast Cancer: Next-Generation Practice Recommendations on Mutation Screening to Guide Therapeutic Decisions - report from SABCS2024
20 Dec 2024
Contributed by Lukas
Virginia Kaklamani, MD, DSc discusses estrogen receptor mutations in HR+ advanced breast cancer and generation practice recommendations on mutation sc...
Anthracyclines May Improve Survival in High-Risk Breast Cancer, But Risks Must Be Weighed - report from SABCS2024
20 Dec 2024
Contributed by Lukas
Nan Chen, MD explains patients with early-stage, node-negative, hormone receptor positive, HER2- negative breast cancer who have a high risk of recurr...
Immunotherapy: Explore Inroads for ER-positive Disease, Challenges Ahead - report from SABCS2024
20 Dec 2024
Contributed by Lukas
Heather McArthur, MD, MPH discusses immunotherapy panel discussion to explore inroads for ER-positive disease, challenges ahead at San Antonio Breast ...
The Winding Road of Immune Biomarkers in Early Breast Cancer - report from SABCS2024
20 Dec 2024
Contributed by Lukas
Sherene Loi, MD discusses immune biomarkers in early breast cancer at San Antonio Breast Cancer Symposium 2024. Video: https://medicaldigest.org/scien...
Palbociclib Plus Endocrine Therapy Beats Chemo in HR+/HER2− Metastatic Breast Cancer - report from SABCS2024
20 Dec 2024
Contributed by Lukas
Prof. Sibylle Loibl presented the findings from the phase 3 PADMA clinical trial at San Antonio Breast Cancer Symposium 2024. Video: https://medicaldi...
COMET Trial Finds Active Monitoring Is a Viable Option for Some Patients With Low-risk DCIS - report from SABCS2024
20 Dec 2024
Contributed by Lukas
Shelley Hwang, MD, MPH discusses active monitoring instead of upfront surgery may be a viable option for patients with hormone receptor-positive, HER2...
Palbociclib Shows Benefit in HR+ HER2+ Metastatic Breast Cancer – the PATINA Trial - report from SABCS2024
20 Dec 2024
Contributed by Lukas
Otto Metzger, MD presented late-breaking results of the phase 3 PATINA trial showing addition of CDK4/6 inhibitor palbociclib to standard therapy led ...
Breast Cancer in Young Women - report from SABCS2024
20 Dec 2024
Contributed by Lukas
Matteo Lambertini, MD, PhD discusses an educational session focus on the management of breast cancer in young women at San Antonio Breast Cancer Sympo...
The Future of Cancer Genetics Is Here - Reversion Mutations in BRCA1/2 in Response to Therapy - report from SABCS2024
20 Dec 2024
Contributed by Lukas
Katherine L. Nathanson, MD discusses reversion mutations in BRCA1/2 in response to therapy at San Antonio Breast Cancer Symposium 2024. Video: https:/...